Please login to the form below

Not currently logged in
Email:
Password:

HTA guidance from NICE, the SMC and the AWMSG

Here we present a feed of upcoming health technology assessment (HTA) decisions, covering appraisals by the National Institute of Health and Care Excellence (NICE), the Scottish Medicines Consortium (SMC) and the All Wales Medicines Strategy Group (AWMSG).

Provided by Guidelines, it also features: NICE clinical guidelines, NICE quality standards, NICE evidence updates, NICE evidence summaries, independent professional body guidelines and (Scottish Intercollegiate Guidelines Network (SIGN) guidance.

Combined hormonal contraception—update (Faculty of Sexual & Reproductive Healthcare)

September 2018: Independent professional body guideline

Asthma (update)

September 2018: NICE Quality Standard

Depression in adults (update)

September 2018: NICE Quality Standard

Eating disorders

September 2018: NICE Quality Standard

Ovarian cancer (refresh)

September 2018: SIGN guidance

Renal replacement therapy

October 2018: NICE Clinical Guideline

Decision making and mental capacity

October 2018: NICE Social Care Guidance

Foetal alcohol spectrum disorder (update)

October 2018: SIGN guidance

Abdominal aortic aneurysm: diagnosis and management

November 2018: NICE Clinical Guideline

Contraceptive choices for women who are obese/overweight

November 2018: Independent professional body guideline

Visit the Guidelines website

NICE backs first cannabis-based drugs, both from GW Pharma

NICE backs first cannabis-based drugs, both from GW Pharma 11 Nov 2019
2014. NICE turned down Epidyolex in  draft guidance, but has changed its stance after a price reduction from the manufacturer. ... Wales and Northern Ireland typically also follow NICE guidance, while the agency’s counterpart in Scotland – the

NICE International relaunches, will offer advisory services

NICE International relaunches, will offer advisory services 7 Nov 2019
optimise their use of evidence-based practice,” said Andrew Dillon, chief executive at NICE. ... NICE has become one of the world’s most prominent and well-know health technology assessment (HTA) bodies since its inception in 1999.

NICE considering re-evaluation of quality of life assessment

NICE considering re-evaluation of quality of life assessment 25 Oct 2019
According to NICE, these valuation studies are ‘technically difficult’, with the study for England being controversial. ... Following the concerns raised, NICE decided not to use the EQ-5D-5L value sets.

Vertex, NHS England and NICE finally reach agreement for Orkambi

Vertex, NHS England and NICE finally reach agreement for Orkambi 24 Oct 2019
reluctance to comply with the National Institute for Health and Care Excellence (NICE) appraisal process. ... will have to submit its full portfolio, including its new triple therapy, for a full NICE appraisal in due course.

SMC approves Yescarta and Keytruda, rejects Perjeta

SMC approves Yescarta and Keytruda, rejects Perjeta 8 Oct 2019
The SMC has approved Yescarta for the treatment for adults patients with certain types of lymphoma as a second-line therapy through its Patient and Clinician Engagement (PACE) process. ... sales. Not-so-lucky was Roche’s Perjeta (pertuzumab),

More news from PMLiVE on NICE, the SMC and the AWMSG

MGP’s Guidelines brand is trusted by over 58,000 healthcare professionals for concise clinical summaries of major primary and shared care guidelines in the UK. Through Guidelines, Guidelines for Nurses and Guidelines in Practice, MGP connect pharmaceutical and medical device companies to an engaged audience of GPs, GP commissioners and payers, nurses and allied healthcare professionals.

To discuss how we can support your guidance or implementation needs please contact marketing@mgp.co.uk

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Infographics